Release date: 2010-03-19
Researchers in the United States have found that cessation of smoking in a year of smoking cessation is greatly improved; although they weigh about four kilograms on average, the risk of cardiovascular disease is significantly reduced by 14%.
The research team at the University of Wisconsin-Madison is targeting 1,504 people over the age of 45 who smoke an average of 21 cigarettes a day.
This group of people received treatment with one of smoking cessation counseling, placebo or five smoking cessation therapies. A year later, 36% of people successfully quit smoking.
The team said at the annual meeting of the American Heart Institute on Monday that they used ultrasound to determine the ability of the quitters to relax the brachial artery.
This test, called flow-mediated dilation, can be used to measure the risk of heart disease, which also determines the function of cells in the arterial wall.
The study found that blood flow adjustment diastolic function improved by 6.2% to 7.2%, and the best score was 10%.
Bovey, the dean of the American Heart Institute, who did not participate in the research, said that 7% does not seem to be much, but it is moving in the right direction.
Arterial wall cells respond to a number of stimuli. Smoking causes platelets to accumulate on the inner wall of the artery.
In the United States, smoking is the leading cause of heart disease, and one in three deaths from heart disease due to smoking.
Quitting smoking also raises high-density lipoprotein, a good cholesterol level. Meditech Medical Network
Monensin Granular,Monensin Growth Promoter,Monensin Antibiotics,Monensin Feed Additives
Shandong Shengli Bioengineering Co., Ltd , https://www.shenglipharm.com